ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCJohn J.V. McMurray, Stamatis Adamopoulos, Stefan D. Anker et al.|European Heart Journal|2012Cited by 6.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012Gerasimos Filippatos, Cândida Fonseca, Tiny Jaarsma et al.|European Journal of Heart Failure|2012Cited by 2.6k
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trialAlexandre Mebazaa, Gad Cotter, Beth A. Davison et al.|The Lancet|2022Cited by 1k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trialAdriaan A. Voors, Piotr Ponikowski, Christiane E. Angermann et al.|Nature Medicine|2022Cited by 889
Mitochondrial function as a therapeutic target in heart failureDavid A. Brown, Mihai Gheorghiade, Justin B. Perry et al.|Nature Reviews Cardiology|2016Cited by 786